The editor in chief of Evidence-Based Oncology calls for universal biomarker testing in every patient, the same standard set for patients in his practice.
Sucharu "Chris" Prakash, MD
Advertisement
Sucharu "Chris" Prakash, MD, is the director of quality services, chair of medical oncology quality, and medical director at Texas Oncology.
Articles by Sucharu "Chris" Prakash, MD
Texas Oncology boosts precision medicine with near-universal biomarker testing, quality measurement, and genomic insights—advancing health equity through streamlined workflows and coverage. This commentary will appear in the June issue of Evidence-Based Oncology.
EBO Editor in Chief Sucharu "Chris" Prakash, MD, addresses the role of nutrition in cancer prevention and treatment.
The editor in chief of Evidence-Based Oncology lauds Congress' authorization of a path for Medicare coverage for multicancer early detection.
Consolidation in oncology is creating access and cost challenges, whereas advocacy helps improve patient care and treatment availability, according to Sucharu "Chris" Prakash, MD.
Advertisement
Latest Updated Articles
New Dietary Guidelines: Blessing or Curse?April 16th 2026
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
Paul Richardson, MD, Calls Mezigdomide “CAR T in a Pill” for Patients With R/R Multiple Myeloma
3
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
4
Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment
5